However, the S100A10 expression level was not highly noticeable in the invasive breast cancers in our in silico analysis; rather S100A11, S100A14, and S100P were markedly elevated in the cancer tissues compared to those in normal breast tissues (Supplementary Figure 1A). Here, S100A11 is linked to breast carcinoma.